Table 3 Morphological abnormally symptoms of peptide 3 (%).

From: Screening and evaluation of therapeutic candidates with vascular protective effects in zebrafish models of diabetic retinopathy

%

CPFE

YSE

PE

BT

HE

Normal

0.0

0.0

0.0

0.0

0.0

50 µg/ml

0.0

0.0

0.0

0.0

0.0

100 µg/ml

2.5

0.0

0.0

0.0

0.0

200 µg/ml

0.0

2.5

0.0

0.0

0.0

400 µg/ml

5.0

0.0

0.0

0.0

0.0

  1. The morphological abnormalities compared to the normal group are expressed as a percentage (%).
Back to article page